Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator.
Clin Pharmacol Drug Dev. 2020 Nov;9(8):1015-1024. doi: 10.1002/cpdd.785. Epub 2020 Apr 1.
Clin Pharmacol Drug Dev. 2020.
PMID: 32237115
A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.
Spiegelstein O, Mimrod D, Rabinovich L, Eyal E, Sprenger C, Elgart A, Samara E, Morganroth J.
Spiegelstein O, et al. Among authors: mimrod d.
Clin Pharmacol Drug Dev. 2019 Jan;8(1):49-59. doi: 10.1002/cpdd.442. Epub 2018 May 22.
Clin Pharmacol Drug Dev. 2019.
PMID: 29786964
Clinical Trial.
Item in Clipboard
The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.
Elgart A, Zur AA, Mimrod D, Dror V, Bar-Ilan O, Korver T, Spiegelstein O.
Elgart A, et al. Among authors: mimrod d.
Eur J Clin Pharmacol. 2019 Jan;75(1):41-49. doi: 10.1007/s00228-018-2549-7. Epub 2018 Sep 6.
Eur J Clin Pharmacol. 2019.
PMID: 30191262
Clinical Trial.
Item in Clipboard
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
Ziemssen T, Tumani H, Sehr T, Thomas K, Paul F, Richter N, Samara E, Spiegelstein O, Sorani E, Bar-Ilan O, Mimrod D, Hayardeny L.
Ziemssen T, et al. Among authors: mimrod d.
J Neuroinflammation. 2017 Aug 31;14(1):172. doi: 10.1186/s12974-017-0945-z.
J Neuroinflammation. 2017.
PMID: 28859672
Free PMC article.
Clinical Trial.
Item in Clipboard
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D, Specchio LM, Britzi M, Perucca E, Specchio N, La Neve A, Soback S, Levy RH, Gatti G, Doose DR, Maryanoff BE, Bialer M.
Mimrod D, et al.
Epilepsia. 2005 Jul;46(7):1046-54. doi: 10.1111/j.1528-1167.2005.06805.x.
Epilepsia. 2005.
PMID: 16026556
Free article.
Item in Clipboard
Dysphagia for medication in Parkinson's disease.
Labeit B, Berkovich E, Claus I, Roderigo M, Schwake AL, Izgelov D, Mimrod D, Ahring S, Oelenberg S, Muhle P, Zentsch V, Wenninger F, Suntrup-Krueger S, Dziewas R, Warnecke T.
Labeit B, et al. Among authors: mimrod d.
NPJ Parkinsons Dis. 2022 Nov 12;8(1):156. doi: 10.1038/s41531-022-00421-9.
NPJ Parkinsons Dis. 2022.
PMID: 36371409
Free PMC article.
Item in Clipboard
Cite
Cite